工信部、国家药监局公布人工智能医疗器械创新任务揭榜挂帅，阿里达摩院入选

Core Insights - The Ministry of Industry and Information Technology and the National Medical Products Administration have announced the selected units for the 2025 AI medical device innovation initiative, with Alibaba's Damo Academy leading the development of the iAorta AI model, which successfully emerged from over 1,000 submissions [1] - The iAorta model aims to reduce misdiagnosis and missed diagnosis of acute aortic syndrome (AAS), a critical cardiovascular condition with a 30% mortality rate within 24 hours of onset [1] - The AI model has been implemented in over ten hospitals nationwide, demonstrating the accelerating integration of AI technology with medical devices [1] Performance Metrics - In a large-scale clinical trial involving 200,000 participants, the iAorta model achieved a sensitivity of 95.5% and specificity of 99.4%, significantly reducing the missed diagnosis rate of AAS from 48.8% to 4.8% [2] - The average diagnosis time was shortened from 4.3 hours to 1.7 hours, exemplified by a case where a patient was diagnosed with aortic dissection within 1.6 hours after initial examination [2] Accessibility and Implementation - The iAorta model requires only standard CT scans for examination, making it deployable in remote areas and grassroots hospitals without the need for additional equipment, thus promoting equitable healthcare access [2] - The Damo Academy plans to collaborate with various hospitals across the country to further promote the iAorta model, with initial partnerships established in Zhejiang and Shandong provinces [2]